Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89


Latent bone metastasis in breast cancer tied to Src-dependent survival signals.

Zhang XH, Wang Q, Gerald W, Hudis CA, Norton L, Smid M, Foekens JA, Massagué J.

Cancer Cell. 2009 Jul 7;16(1):67-78. doi: 10.1016/j.ccr.2009.05.017.


Breast cancer SRC activity: bad to the bone.

Sgroi DC.

Cancer Cell. 2009 Jul 7;16(1):1-2. doi: 10.1016/j.ccr.2009.06.010.


Comparative role of acetylation along c-SRC/ETS1 signaling pathway in bone metastatic and invasive mammary cell phenotypes.

Bendinelli P, Maroni P, Matteucci E, Desiderio MA.

Biochim Biophys Acta. 2011 Oct;1813(10):1767-76. doi: 10.1016/j.bbamcr.2011.06.004. Epub 2011 Jun 29.


ANGPTL2 increases bone metastasis of breast cancer cells through enhancing CXCR4 signaling.

Masuda T, Endo M, Yamamoto Y, Odagiri H, Kadomatsu T, Nakamura T, Tanoue H, Ito H, Yugami M, Miyata K, Morinaga J, Horiguchi H, Motokawa I, Terada K, Morioka MS, Manabe I, Iwase H, Mizuta H, Oike Y.

Sci Rep. 2015 Mar 16;5:9170. doi: 10.1038/srep09170. Erratum in: Sci Rep. 2015;5:9789.


TRAIL-R2 promotes skeletal metastasis in a breast cancer xenograft mouse model.

Fritsche H, Heilmann T, Tower RJ, Hauser C, von Au A, El-Sheikh D, Campbell GM, Alp G, Schewe D, Hübner S, Tiwari S, Kownatzki D, Boretius S, Adam D, Jonat W, Becker T, Glüer CC, Zöller M, Kalthoff H, Schem C, Trauzold A.

Oncotarget. 2015 Apr 20;6(11):9502-16.


CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.

Chinni SR, Sivalogan S, Dong Z, Filho JC, Deng X, Bonfil RD, Cher ML.

Prostate. 2006 Jan 1;66(1):32-48.


CXCL12-γ in primary tumors drives breast cancer metastasis.

Ray P, Stacer AC, Fenner J, Cavnar SP, Meguiar K, Brown M, Luker KE, Luker GD.

Oncogene. 2015 Apr 16;34(16):2043-51. doi: 10.1038/onc.2014.157. Epub 2014 Jun 9.


Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma.

Zhang XH, Jin X, Malladi S, Zou Y, Wen YH, Brogi E, Smid M, Foekens JA, Massagué J.

Cell. 2013 Aug 29;154(5):1060-73. doi: 10.1016/j.cell.2013.07.036.


The ubiquitin E3 ligase WWP1 decreases CXCL12-mediated MDA231 breast cancer cell migration and bone metastasis.

Subik K, Shu L, Wu C, Liang Q, Hicks D, Boyce B, Schiffhauer L, Chen D, Chen C, Tang P, Xing L.

Bone. 2012 Apr;50(4):813-23. doi: 10.1016/j.bone.2011.12.022. Epub 2012 Jan 11.


Radiation-induced lung damage promotes breast cancer lung-metastasis through CXCR4 signaling.

Feys L, Descamps B, Vanhove C, Vral A, Veldeman L, Vermeulen S, De Wagter C, Bracke M, De Wever O.

Oncotarget. 2015 Sep 29;6(29):26615-32. doi: 10.18632/oncotarget.5666.


ErbB2 promotes Src synthesis and stability: novel mechanisms of Src activation that confer breast cancer metastasis.

Tan M, Li P, Klos KS, Lu J, Lan KH, Nagata Y, Fang D, Jing T, Yu D.

Cancer Res. 2005 Mar 1;65(5):1858-67.


Osteolytic bone metastasis is hampered by impinging on the interplay among autophagy, anoikis and ossification.

Maroni P, Bendinelli P, Matteucci E, Locatelli A, Nakamura T, Scita G, Desiderio MA.

Cell Death Dis. 2014 Jan 16;5:e1005. doi: 10.1038/cddis.2013.465.


Akt plays an important role in breast cancer cell chemotaxis to CXCL12.

Zhao M, Mueller BM, DiScipio RG, Schraufstatter IU.

Breast Cancer Res Treat. 2008 Jul;110(2):211-22. Epub 2007 Aug 9.


In vivo bone metastases, osteoclastogenic ability, and phenotypic characterization of human breast cancer cells.

Rucci N, Ricevuto E, Ficorella C, Longo M, Perez M, Di Giacinto C, Funari A, Teti A, Migliaccio S.

Bone. 2004 Apr;34(4):697-709.


Inhibitory effect of HGF on invasiveness of aggressive MDA-MB231 breast carcinoma cells, and role of HDACs.

Ridolfi E, Matteucci E, Maroni P, Desiderio MA.

Br J Cancer. 2008 Nov 18;99(10):1623-34. doi: 10.1038/sj.bjc.6604726. Epub 2008 Oct 21.


C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis.

Myoui A, Nishimura R, Williams PJ, Hiraga T, Tamura D, Michigami T, Mundy GR, Yoneda T.

Cancer Res. 2003 Aug 15;63(16):5028-33.


Csk homologous kinase inhibits CXCL12-CXCR4 signaling in neuroblastoma.

Zagozdzon R, Fu Y, Avraham HK.

Int J Oncol. 2008 Mar;32(3):619-23.


Hormone receptor-independent CXCL10 production is associated with the regulation of cellular factors linked to breast cancer progression and metastasis.

Ejaeidi AA, Craft BS, Puneky LV, Lewis RE, Cruse JM.

Exp Mol Pathol. 2015 Aug;99(1):163-72. doi: 10.1016/j.yexmp.2015.06.002. Epub 2015 Jun 14.


The tyrosine kinase Abl is required for Src-transforming activity in mouse fibroblasts and human breast cancer cells.

Sirvent A, Boureux A, Simon V, Leroy C, Roche S.

Oncogene. 2007 Nov 15;26(52):7313-23. Epub 2007 May 28.


Supplemental Content

Support Center